Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 12400 High Bluff Drive SAN DIEGO CA 92130 |
Tel: | N/A |
Website: | https://www.tandemdiabetes.com |
IR: | See website |
Key People | ||
Leigh A. Vosseller Chief Financial Officer, Executive Vice President, Treasurer | Susan M. Morrison Executive Vice President, Chief Administrative Officer | Elizabeth A. Gasser Executive Vice President, Chief Strategy Officer |
Brian B. Hansen Chief Commercial Officer, Executive Vice President | James A. Leal Senior Vice President - Operations | Rick Carpenter Chief Technical Officer |
Business Overview |
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors. |
Financial Overview |
For the fiscal year ended 31 December 2023, Tandem Diabetes Care Inc revenues decreased 7% to $747.7M. Net loss increased from $94.6M to $222.6M. Revenues reflect Pump segment decrease of 13% to $374.3M. Higher net loss reflects Acquired in-process research and develop increase from $31M to $78.8M (expense), Research and development - Balancing val increase of 21% to $144.1M (expense). |
Employees: | 2,400 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $1,847M as of Dec 31, 2023 |
Annual revenue (TTM): | $747.72M as of Dec 31, 2023 |
EBITDA (TTM): | -$206.29M as of Dec 31, 2023 |
Net annual income (TTM): | -$222.61M as of Dec 31, 2023 |
Free cash flow (TTM): | -$83.41M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 65,631,041 as of Feb 16, 2024 |
Index Membership: | S&P 600 Small Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |